Whalen J, Earley J, Wisniewski C, Mercurio A, Cantor S
Nat Cancer. 2025; 6(2):278-291.
PMID: 39838098
DOI: 10.1038/s43018-024-00902-1.
Hamrick A, Cope H, Forbis D, Rog O
bioRxiv. 2025; .
PMID: 39829846
PMC: 11741252.
DOI: 10.1101/2025.01.10.632442.
Ananthaswamy D, Funes K, Borges T, Roques S, Fassnacht N, Jamal S
bioRxiv. 2024; .
PMID: 39314477
PMC: 11419128.
DOI: 10.1101/2024.09.14.613027.
Yin H, Zhou Z, Fu C
Reprod Biol Endocrinol. 2024; 22(1):113.
PMID: 39210375
PMC: 11360510.
DOI: 10.1186/s12958-024-01284-w.
Chauvin S, Ando S, Holley J, Sugie A, Zhao F, Poddar S
Nat Commun. 2024; 15(1):4696.
PMID: 38824133
PMC: 11144269.
DOI: 10.1038/s41467-024-49066-7.
Whole exome sequencing of a novel homozygous missense variant in gene leading to Fanconi anaemia complementation group.
Abdulkareem A, Shirah B, Bagabir H, Haque A, Naseer M
Biomed Rep. 2024; 20(4):67.
PMID: 38476606
PMC: 10928473.
DOI: 10.3892/br.2024.1756.
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair.
Khazaei Monfared Y, Heidari P, Klempner S, Mahmood U, Parikh A, Hong T
Pharmaceutics. 2023; 15(12).
PMID: 38140100
PMC: 10748326.
DOI: 10.3390/pharmaceutics15122761.
Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining.
Rogers C, Kram R, Lin K, Myers C, Sobeck A, Hendrickson E
Cell Rep. 2023; 42(5):112428.
PMID: 37086407
PMC: 10321316.
DOI: 10.1016/j.celrep.2023.112428.
Pathological consequences of DNA damage in the kidney.
Garaycoechea J, Quinlan C, Luijsterburg M
Nat Rev Nephrol. 2023; 19(4):229-243.
PMID: 36702905
DOI: 10.1038/s41581-022-00671-z.
Identification of a Hypomorphic Variant in Bernese Mountain Dogs.
Meek K, Yang Y, Takada M, Parys M, Richter M, Engleberg A
Genes (Basel). 2022; 13(10).
PMID: 36292578
PMC: 9601343.
DOI: 10.3390/genes13101693.
Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms.
Al Ahmad Nachar B, Rosselli F
Int J Mol Sci. 2022; 23(19).
PMID: 36232633
PMC: 9570362.
DOI: 10.3390/ijms231911331.
DNA-PKcs promotes fork reversal and chemoresistance.
Dibitetto D, Marshall S, Sanchi A, Liptay M, Badar J, Lopes M
Mol Cell. 2022; 82(20):3932-3942.e6.
PMID: 36130596
PMC: 9588680.
DOI: 10.1016/j.molcel.2022.08.028.
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer.
Taylor S, Arends M, Langdon S
Explor Target Antitumor Ther. 2022; 1(1):26-52.
PMID: 36046263
PMC: 9400734.
DOI: 10.37349/etat.2020.00003.
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.
Mekonnen N, Yang H, Shin Y
Front Oncol. 2022; 12:880643.
PMID: 35785170
PMC: 9247200.
DOI: 10.3389/fonc.2022.880643.
HIV-1 exploits the Fanconi anemia pathway for viral DNA integration.
Fu S, Phan A, Mao D, Wang X, Gao G, Goff S
Cell Rep. 2022; 39(8):110840.
PMID: 35613597
PMC: 9250337.
DOI: 10.1016/j.celrep.2022.110840.
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.
Peake J, Noguchi E
Hum Genet. 2022; 141(12):1811-1836.
PMID: 35596788
DOI: 10.1007/s00439-022-02462-9.
Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
Chihanga T, Vicente-Munoz S, Ruiz-Torres S, Pal B, Sertorio M, Andreassen P
Cancers (Basel). 2022; 14(8).
PMID: 35454946
PMC: 9025423.
DOI: 10.3390/cancers14082040.
Self-DNA Exposure Induces Developmental Defects and Germline DNA Damage Response in .
Germoglio M, Adamo A, Incerti G, Carteni F, Gigliotti S, Storlazzi A
Biology (Basel). 2022; 11(2).
PMID: 35205128
PMC: 8869574.
DOI: 10.3390/biology11020262.
Type-I Interferon Signaling in Fanconi Anemia.
Landelouci K, Sinha S, Pepin G
Front Cell Infect Microbiol. 2022; 12:820273.
PMID: 35198459
PMC: 8859461.
DOI: 10.3389/fcimb.2022.820273.
DNA repair, recombination, and damage signaling.
Gartner A, Engebrecht J
Genetics. 2022; 220(2).
PMID: 35137093
PMC: 9097270.
DOI: 10.1093/genetics/iyab178.